Campbell & CO Investment Adviser LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1353570 BALTIMORE, MD

Position in ALNY

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$3,366,418

-$407,280 QoQ

Shares Held

11,183

+17.8% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#262

of 764 holders

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Campbell & CO Investment Adviser LLC holds $72,173,828 across 47 Biotechnology names. ALNY ranks #7 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	9,899	$6,172,422
2	CRSP	CRISPR Therapeutics AG	107,529	$5,864,631
3	CYTK	Cytokinetics Inc	65,978	$5,620,665
4	INSM	INSMED Inc	43,856	$4,675,926
5	IONS	Ionis Pharmaceuticals Inc	49,632	$3,935,321
6	HALO	Halozyme Therapeutics, Inc.	44,702	$3,498,825
7	ALNY	Alnylam Pharmaceuticals, Inc. This page	11,183	$3,366,418
8	RPRX	Royalty Pharma plc	52,688	$2,954,216

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,366,418	11,183	+17.8%	Shares	Sole	2026-08-03
2025-12-31	$3,773,698	9,490	-25.3%	Shares	Sole	2026-02-12
2025-09-30	$5,789,832	12,697	-24.7%	Shares	Sole	2025-10-28
2024-12-31	$3,966,855	16,858	+58.8%	Shares	Sole	2025-02-10
2024-03-31	$1,586,262	10,614	-54.6%	Shares	Sole	2024-05-10
2023-12-31	$4,473,443	23,371	+813.6%	Shares	Sole	2024-02-13
2022-09-30	$512,009	2,558	-53.8%	Shares	Sole	2022-11-14
2022-06-30	$808,154	5,541	+94.3%	Shares	Sole	2022-08-09
2022-03-31	$465,703	2,852	+119.4%	Shares	Sole	2022-05-09
2021-09-30	$245,453	1,300	—	Shares	Sole	2021-11-10
No filing history on record for this holder in this stock.